CONMED | CNMD - 销售成本



金融业
股票价格
USD
资产
USD 2.33B
现金及等价物
USD 40.82M
销售成本
USD 154.91M
流动资产
USD 672.86M
流动负债
USD 315.04M
债务
USD 834.94M
股息收益率
1.48
EBIT
USD 36.62M
EBITDA
USD 80.36M
员工
3.9K
EPS每股收益
USD 0.89
股本和储备
USD 1.03B
销售毛利
USD 218.29M
债务利息支出
USD 7.37M
贷款资金
USD 834.23M
市值
USD 1.12B
净收入
USD 16.74M
营业费用
USD 336.58M
营业利润
USD 36.62M
普通股股本
USD 30.97M
PE价格收益
26.88
税前利润
USD 29.25M
销售收入
USD 317M
销售和管理费用
USD 166.76M
股票
USD 355.54M
贸易债权人
USD 93.65M
应收帐款人
USD 247.83M


销售成本 更改 日
3M USD 3.57B 501M 2026-03
Abbott USD 5.3B 380M 2026-03
Accuray USD 116.17M 14.63M 2024-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
CONMED USD 154.91M 16.9M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 290.47M 8.09M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Olympus JPY 96.15B 9.61B 2025-12
Orthofix International USD 66.63M 6.4M 2025-12
ResMed USD 555.85M 29.13M 2025-12
Smith & Nephew USD 870M 17M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03